BACKGROUND: Exercise improves quality of life (QOL) in cancer survivors, although characteristics of efficacious exercise interventions for this population have not been identified. PURPOSE: The present meta-analysis examines the efficacy of exercise interventions in improving QOL in cancer survivors, as well as features that may moderate such effects. METHOD: Studies were identified and coded, and QOL effect sizes were calculated and analyzed for trends. RESULTS: Overall, exercise interventions increased QOL, but this tendency depended to some extent on exercise and patient features. Although several features were associated with effect sizes, models revealed that interventions were particularly successful if they targeted more intense aerobic exercise and addressed women. These tendencies emerged over longer periods of time and were more prominent in studies with higher methodological quality. CONCLUSION: Appropriately designed exercise interventions enhance QOL for cancer survivors and this pattern is especially evident for women. Limitations are discussed.
BACKGROUND: Exercise improves quality of life (QOL) in cancer survivors, although characteristics of efficacious exercise interventions for this population have not been identified. PURPOSE: The present meta-analysis examines the efficacy of exercise interventions in improving QOL in cancer survivors, as well as features that may moderate such effects. METHOD: Studies were identified and coded, and QOL effect sizes were calculated and analyzed for trends. RESULTS: Overall, exercise interventions increased QOL, but this tendency depended to some extent on exercise and patient features. Although several features were associated with effect sizes, models revealed that interventions were particularly successful if they targeted more intense aerobic exercise and addressed women. These tendencies emerged over longer periods of time and were more prominent in studies with higher methodological quality. CONCLUSION: Appropriately designed exercise interventions enhance QOL for cancer survivors and this pattern is especially evident for women. Limitations are discussed.
Authors: Vicki S Conn; Adam R Hafdahl; Davina C Porock; Roxanne McDaniel; Paul J Nielsen Journal: Support Care Cancer Date: 2006-01-31 Impact factor: 3.603
Authors: Wendy Demark-Wahnefried; Elizabeth C Clipp; Miriam C Morey; Carl F Pieper; Richard Sloane; Denise Clutter Snyder; Harvey J Cohen Journal: J Clin Oncol Date: 2006-07-20 Impact factor: 44.544
Authors: Stephen J Freedland; William J Aronson; Christopher J Kane; Joseph C Presti; Christopher L Amling; David Elashoff; Martha K Terris Journal: J Clin Oncol Date: 2003-12-22 Impact factor: 44.544
Authors: Roberto D K S Liu; Marijke J M Chinapaw; Peter C Huijgens; Willem van Mechelen Journal: Cancer Treat Rev Date: 2008-11-11 Impact factor: 12.111
Authors: K S Courneya; C M Friedenreich; H A Quinney; A L A Fields; L W Jones; A S Fairey Journal: Eur J Cancer Care (Engl) Date: 2003-12 Impact factor: 2.520
Authors: Kirsten A Nyrop; Allison M Deal; Grant R Williams; Emily J Guerard; Mackenzi Pergolotti; Hyman B Muss Journal: Cancer Date: 2015-11-13 Impact factor: 6.860
Authors: Hendrik Mugele; Nils Freitag; Jannik Wilhelmi; Yanxiang Yang; Sulin Cheng; Wilhelm Bloch; Moritz Schumann Journal: J Cancer Surviv Date: 2019-02-26 Impact factor: 4.442
Authors: Justin P Hardee; Ryan R Porter; Xuemei Sui; Edward Archer; I-Min Lee; Carl J Lavie; Steven N Blair Journal: Mayo Clin Proc Date: 2014-06-21 Impact factor: 7.616
Authors: Rachel Ballard-Barbash; Sameer M Siddiqi; David A Berrigan; Sharon A Ross; Linda C Nebeling; Emily C Dowling Journal: Am J Prev Med Date: 2013-04 Impact factor: 5.043
Authors: Jennifer L Beebe-Dimmer; Julie J Ruterbusch; Felicity W K Harper; Tara M Baird; David G Finlay; Andrew G Rundle; Stephanie S Pandolfi; Theresa A Hastert; Kendra L Schwartz; Gerold Bepler; Michael S Simon; Julia Mantey; Judy Abrams; Teri L Albrecht; Ann G Schwartz Journal: Cancer Date: 2020-02-24 Impact factor: 6.860